Edward Stacey
Managing Partner @ IQ Capital
Cambridge, United Kingdom
Edward Stacey is a seed investor at IQ Capital in Cambridge focused on Software and Information Technology. Edward Paul Stacey is based out of Cambridge, Cambridgeshire and is the Managing Partner of IQ Capital. Edward previously worked at Venture Technologies as a Director. Edward Paul Stacey attended the Alliance Manchester Business School.
- Total investments:
- 50
- Last investment:
- Lead investor:
- 42%
Last updated:
For AI agents: llms.txt
Industries Edward Stacey invests in
Stages Edward Stacey invests in
Countries Edward Stacey invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 9 (18%)
- Information Technology 9 (18%)
- Machine Learning 6 (12%)
- Artificial Intelligence 6 (12%)
- Enterprise Software 4 (8%)
Stage
- Seed 16 (32%)
- Series A 11 (22%)
- Funding Round 5 (10%)
- Pre-Seed 3 (6%)
- Series B 3 (6%)
Country
- United Kingdom 21 (42%)
- United States 2 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Nu Quantum is a telecommunications company that develops end-to-end quantum cryptography systems.It secures communications within and between cities through urban and satellite free-space optical links. The system helps with the realization of commercial deliverable photonic technologies by combining novel materials and semiconductor technology.This enables clients to secure the exchange of cryptographic keys for the ultra-sensitive detection of light.Yuri Andersson, Mete Atatüre, and Carmen Berraquero founded Nu Quantum in Cambridge, Cambridgeshire in 2018. | $71.1M / Series A / Dec 10, 2025 | ||
| AiM Medical Robotics developing a robotic system for use in neurosurgical procedures. The system is unique in that it is MRI compatible, allowing patients to be treated while in the MRI scanner. This gives physicians the ability to capture real-time imaging feedback to improve outcomes. Its system will help treat patients with Parkinson's,Epilepsy, Tremors, and brain cancer. | $8.1M / Series A / Sep 30, 2025 | ||
| AI-powered test data automation platform. Synthesized eliminates test data bottlenecks, enabling enterprises to test faster, more securely, and at scale.Modern software development demands continuous testing, but legacy test data management is slow, costly, and filled with compliance risks. Synthesized automates test data generation,provisioning, and execution, ensuring CI/CD-ready, production-like datasets—without exposing sensitive information.Synthesized delivers AI-native test data infrastructure, transforming enterprise software testing by eliminating manual bottlenecks and accelerating QA cycles.- AI-powered test data automation – Autonomous test data generation & provisioning - Seamless DevOps & CI/CD integration – No delays, no manual setup - Enterprise-Ready – Snowflake, Oracle, SQL Server, PostgreSQL, Salesforce, SAP, Workday, and more - Regulatory Compliance – GDPR, SOC2, HIPAA-ready synthetic & masked test data - Trusted by Industry Leaders – Used by Deutsche Bank, UBS, European Commission, and global enterprisesJoin the future of AI-driven test automation. | $20M / Series A / Sep 24, 2025 | ||
| Unlock the full potential of your code and data with GenAI.TurinTech AI is the leader in automated code optimisation for machine learning and data-heavy applications. We utilise our proprietary optimisation algorithms and LLMs to speed up the time-to-production for your ML projects and applications, cutting computational costs and minimisingcarbon emissions.Learn more at https://turintech.ai/ | $15M / Series A / Mar 18, 2025 | ||
| Cambridge GaN Devices develops transistors designed to bring widespread adoption of GaN technology in consumer electronics. | $32M / Series C / Feb 18, 2025 | ||
| Nu Quantum is a telecommunications company that develops end-to-end quantum cryptography systems.It secures communications within and between cities through urban and satellite free-space optical links. The system helps with the realization of commercial deliverable photonic technologies by combining novel materials and semiconductor technology.This enables clients to secure the exchange of cryptographic keys for the ultra-sensitive detection of light.Yuri Andersson, Mete Atatüre, and Carmen Berraquero founded Nu Quantum in Cambridge, Cambridgeshire in 2018. | $8.5M / Seed / Nov 02, 2023 | ||
| Signaloid provides hardware and cloud-based compute platforms for probabilistic computing workloads. Our hardware and cloud-based platforms enable organizations to implement faster solutions to challenges ranging from particle filters in robotics, detecting hallucinations in LLMs to implementing better, to faster quantitative finance models. Ourunderlying technology natively supports computation on probability distributions and is designed to reduce the runtime and infrastructure costs of workloads across applications ranging from numerical solution of stochastic differential equations to randomized numerical linear algebra. | $3.7M / Seed / May 25, 2023 | ||
| Cambridge GaN Devices develops transistors designed to bring widespread adoption of GaN technology in consumer electronics. | $19M / Series B / Nov 15, 2022 | ||
| TOffeeAM optimizes product designs for 3D printing. TOffeeAM creates structures within smart industrial production, such as coolant systems for gas turbines exceeding the performance of current heat exchangers. | $5.8M / Series A / Nov 08, 2022 | ||
| Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology. | $4.3M / Seed / Aug 02, 2022 | ||
| See all 50 investments → | |||
Co-Investors
About IQ Capital
IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.
IQ Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrey Kessel
Entrepreneur in Residence / Hands on work with startups
|
|||
Daniel Carew
Principal
|
|||
Daniil Shcherbakov
MBA Consultant
|
|||
|
Edward Stacey
Managing Partner
|
|||
Kerry Baldwin
Managing Partner, co-founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Edward Stacey invest in?
Edward Stacey invests primarily in Software, Information Technology and Machine Learning startups, most often at Seed and Series A stage. Most of the 50 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Edward Stacey?
Public channels for Edward Stacey include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Edward Stacey last invest?
The most recent investment recorded for Edward Stacey closed in Dec 2025. Shizune tracks 50 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
